COVID-19 IgG/IgM Rapid Test Cassette. FDA EUA CE Approved for Professional Use. Box of 25 – Only $9/Test!

4.50 out of 5 Based on 2 ratings

$395.00 $225.00

-43% New

These tests are in limited stock. Please give us a call at 215-907-3967 or email: avazo.co@gmail.com.

8 in stock

Qty:

READ OUR TERMS & CONDITIONS, FACT SHEET FOR HEALTHCARE PROVIDERS, and FACT SHEET FOR RECIPIENTS.

The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals.

Coronaviruses are enveloped RNA viruses that are distributed broadly among humans, other mammals, and birds that cause respiratory, enteric, hepatic, and neurological diseases. Four viruses – 229E, OC43, NL63, and HKU1 are prevalent and typically cause common cold symptoms in immunocompromised individuals. Three other strains SARS-CoV, MERS-CoV, and SARS-CoV-2 (COVID-19) are can be transmitted from between non-human vertebrates to humans.

Video Instructions How to Use Available HERE

Warning
This test has been authorized by FDA under a EUA for use by authorized laboratories.
This test has not been FDA cleared or approved.
This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens.
This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
This product is intended for professional use and not for home use.
Not for the screening of donated blood.

Healgen Scientific

Healgen Scientific

Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co.,Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. Our product portfolio spans multiple testing categories and analytes to meet various clinical and laboratory needs. Our testing platforms include rapid testing, molecular diagnostics, and multiplex flow cytometry. Since our inception in 2007, we have strived to develop devices that meet and exceed industry standards. The manufacturing process is supported by our interactive and highly-skilled Research and Development team, who are actively redefining the efficiency and design of our products.

Our ambition is worldwide, and we currently provide products to customers in: USA, Europe, Middle-East, South Asia, Africa and Latin America for a total of 80+ countries.  Our mission is to provide premier support to our distributors and partners. We have a flexible strategy on business cooperation, where we offer OEM options.  Our success is supported by our professional personnel and good manufacturing practice.